Molecular mechanisms in hepatocellular carcinoma development

Best Practice and Research: Clinical Gastroenterology

Volumn 19, Issue 1 SPEC. ISS., 2005, Pages 25-37

  Cha, Charles ^a   DeMatteo, Ronald P ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aflatoxin; Cirrhosis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Molecular; Oncogenes; p53; Tumor suppressor genes

Indexed keywords

AFLATOXIN; ALCOHOL; ANTIVIRUS AGENT; HEPATITIS B VACCINE; RNA;

ADVANCED CANCER; ANGIOGENESIS; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; DNA METHYLATION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; HEPATITIS B; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; ONCOGENE; PATHOGENESIS; PROGNOSIS; PROTEOMICS; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS HEPATITIS;

EID: 14744291990     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2004.11.005     Document Type: Review

References (112)

1. HB El-Serag A.J. Davil et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update Ann Intern Med 139 10 2003 817-823
2. HB El-Serag A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 10 1999 745-750
3. B. Di R.L. Carithers G.J. Gores Hepatocellular carcinoma Hepatology 28 4 1998 1161-1165
4. B. Di L.H. Simpson M.T. Lotze J.H. Hoofnagle Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection J Clin Gastroenterol 19 3 1994 222-226
5. R.P. Beasley Hepatitis B virus. The major etiology of hepatocellular carcinoma Cancer 61 10 1988 1942-1956
6. K. Okuda T. Ohtsuki H. Obata et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 4 1985 918-928
7. N. Nagasue H. Yukaya T. Hamada et al. The natural history of hepatocellular carcinoma. A study of 100 untreated cases Cancer 54 7 1984 1461-1465
8. P. Attali H. Prod G. Pelletier et al. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival Cancer 59 12 1987 2108-2111
9. X. Calvet J. Bruix P. Gines et al. Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients Hepatology 12 4 Pt 1 1990 753-760
10. C.H. Cha L. Ruo Y. Fong et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation Ann Surg 238 3 2003 315-321
11. R.T. Poon S.T. Fan C.M. Lo et al. Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years Ann Surg 234 1 2001 63-70
12. H. Unsal C. Yakicier C. Marcais et al. Genetic-heterogeneity of hepatocellular-carcinoma Proc Natl Acad Sci USA 91 2 1994 822-826
13. S.N. Huang F.V. Chisari Sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis-B surface-antigen transgenic mice Hepatology 21 3 1995 620-626
14. A.G. Knudson Jr Mutation and cancer: Statistical study of retinoblastoma Proc Natl Acad Sci USA 68 4 1971 820-823
15. E.R. Fearon B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 5 1990 759-767
16. B. Vogelstein E.R. Fearon S.R. Hamilton Genetic alterations during colorectal-tumor development New Engl J Med 319 9 1988 525-532
17. S.S. Thorgeirsson J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 4 2002 339-346
18. F. Staib S.P. Hussain L.J. Hofseth TP53 and liver carcinogenesis Hum Mutat 21 3 2003 201-216
19. S.E. Kern J.A. Pietenpol S. Thiagalingam et al. Oncogenic forms of p53 inhibit p53-regulated gene-expression Science 256 5058 1992 827-830
20. N. Nishida Y. Fukuda H. Kokuryu et al. Role and mutational heterogeneity of the p53-gene in hepatocellular-carcinoma Cancer Res 53 2 1993 368-372
21. T. Teramoto K. Satonaka S. Kitazawa et al. P53 Gene abnormalities are closely-related to hepatoviral infections and occur at a late-stage of hepatocarcinogenesis Cancer Res 54 1 1994 231-235
22. Y. Murakami K. Hayashi S. Hirohashi T. Sekiya Aberrations of the tumor suppressor-p53 and retinoblastoma genes in human hepatocellular carcinomas Cancer Res 51 20 1991 5520-5525
23. T. Oda H. Tsuda A. Scarpa et al. P53 Gene mutation spectrum in hepatocellular-carcinoma Cancer Res 52 22 1992 6358-6364
24. G.N. Wogan Aflatoxins as risk-factors for hepatocellular-carcinoma in humans Cancer Res 52 7 1992 S2114-S2118
25. P. Coursaget N. Depril M. Chabaud et al. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from senegal Br J Cancer 67 6 1993 1395-1397
26. Y. Fujimoto L.L. Hampton P.J. Wirth Alterations of tumor-suppressor genes and allelic losses in human hepatocellular carcinomas in China Cancer Res 54 1 1994 281-285
27. I.C. Hsu R.A. Metcalf T. Sun et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature 350 6317 1991 427-428
28. D.Z. Li Y.Q. Cao L.P. He et al. Aberrations of P53 gene in human hepatocellular-carcinoma from China Carcinogenesis 14 2 1993 169-173
29. M. Ozturk P53 Mutation in hepatocellular-carcinoma after aflatoxin exposure Lancet 338 8779 1991 1356-1359
30. B. Bressac M. Kew J. Wands M. Ozturk Selective G-mutation to T-mutation of P53 gene in hepatocellular-carcinoma from Southern Africa Nature 350 6317 1991 429-431
31. J.C. Sheu G.T. Huang P.H. Lee et al. Mutation of P53 gene in hepatocellular-carcinoma in Taiwan Cancer Res 52 21 1992 6098-6100
32. N. Nishida K. Ishizaki Y. Fukuda et al. Accumulation of allelic loss in the advanced stages of human hepatocellular-carcinoma Hepatology 16 2 1992 577
33. S. Kar R. Jaffe B.I. Carr Mutation at Codon-249 of P53 gene in a human hepatoblastoma Hepatology 18 3 1993 566-569
34. F. Aguilar C.C. Harris T. Sun et al. Geographic-variation of p53 mutational profile in nonmalignant human liver Science 264 5163 1994 1317-1319
35. K.A. Scorsone Y.Z. Zhou J.S. Butel B.L. Slagle P53 Mutations cluster at Codon-249 in hepatitis-B virus-positive hepatocellular carcinomas from China Cancer Res 52 6 1992 1635-1638
36. G.S. Qian R.K. Ross M.C. Yu et al. A follow-up-study of urinary markers of aflatoxin exposure and liver-cancer risk in Shanghai, Peoples-Republic-of-China Cancer Epidemiol Biomarkers Prev 3 1 1994 3-10
37. R.K. Ross J.M. Yuan M.C. Yu et al. Urinary aflatoxin biomarkers and risk of hepatocellular-carcinoma Lancet 339 8799 1992 943-946
38. F. Aguilar S.P. Hussain P. Cerutti Aflatoxin-B(1) induces the transversion of g-]t in codon 249 of the p53 tumor-suppressor gene in human hepatocytes Proc Natl Acad Sci USA 90 18 1993 8586-8590
39. M. Geissler A. Gesien J.R. Wands Molecular mechanisms of hepatocarcinogenesis. In: K. Okuda E. Tabor (eds.) Liver Cancer 1997 Churchhill Livingstone New York 59-88
40. Z. Piao H. Kim B.K. Jeon et al. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma Cancer 80 5 1997 865-872
41. T. Nakamura Y. Iwamura M. Kaneko et al. Deletions and rearrangements of the retinoblastoma gene in hepatocellular-carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors Jpn J Clin Oncol 21 5 1991 325-329
42. N. Nishida Y. Fukuda T. Komeda et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular-carcinoma Cancer Res 54 12 1994 3107-3110
43. E. Tabor Tumor-Suppressor genes. Growth-factor genes, and oncogenes in hepatitis-B virus-associated hepatocellular-carcinoma J Med Virol 42 4 1994 357-365
44. X. Zhang H.J. Xu Y. Murakami et al. Deletions of chromosome 13Q. Mutations in retinoblastoma-1, and retinoblastoma protein state in human hepatocellular-carcinoma Cancer Res 54 15 1994 4177-4182
45. J. Yu M. Ni J. Xu Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis Bmc Cancer 2002 2
46. C.T. Liew H.M. Li K.W. Lo et al. High frequency of p16(ink4a) gene alterations in hepatocellular carcinoma Oncogene 18 3 1999 789-795
47. Y. Matsuda T. Ichida J. Matsuzawa et al. P16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma Gastroenterology 116 2 1999 394-400
48. B. Yang M.Z. Guo J.G. Herman D.P. Clark Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma Am J Pathol 163 3 2003 1101-1107
49. H. Tsuda S. Hirohashi Y. Shimosato et al. Low incidence of point mutation of C-Ki-Ras and N-Ras oncogenes in human hepatocellular-carcinoma Jpn J Cancer Res 80 3 1989 196-199
50. N. Ogata T. Kamimura H. Asakura Point mutation. Allelic loss and increased methylation of C-Ha-Ras gene in human hepatocellular-carcinoma Hepatology 13 1 1991 31-37
51. P. Stork M. Loda S. Bosari et al. Detection of K-Ras mutations in pancreatic and hepatic neoplasms by nonisotopic mismatched polymerase chain-reaction Oncogene 6 5 1991 857-862
52. M. Tada O. Yokosuka M. Omata et al. Analysis of Ras gene-mutations in biliary and pancreatic tumors by polymerase chain-reaction and direct sequencing Cancer 66 5 1990 930-935
53. J.D. Collier K. Guo J. Mathew et al. C-erbb-2 oncogene expression in hepatocellular-carcinoma and cholangiocarcinoma J Hepatol 14 2-3 1992 377-380
54. L. Boix J.L. Rosa F. Ventura et al. C-met messenger-RNA overexpression in human hepatocellular-carcinoma Hepatology 19 1 1994 88-91
55. T. Ueki J. Fujimoto T. Suzuki et al. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma Hepatology 25 4 1997 862-866
56. D. Ganem A.M. Prince Mechanisms of disease: Hepatitis B virus infection-natural history and clinical consequences New Engl J Med 350 11 2004 1118-1129
57. R.P. Beasley C.C. Lin L.Y. Hwang C.S. Chien Hepatocellular-carcinoma and hepatitis-B virus-a prospective-study of 22707 men in Taiwan Lancet 2 8256 1981 1129-1133
58. C. Brechot C. Pourcel A. Louise et al. Presence of integrated hepatitis-B virus-DNA sequences in cellular DNA of human hepatocellular-carcinoma Nature 286 5772 1980 533-535
59. D.S. Chen B.H. Hoyer J. Nelson et al. Detection and properties of hepatitis-B viral-DNA in liver-tissues from patients with hepatocellular-carcinoma Hepatology 2 2 1982 S42-S46
60. K. Matsubara T. Tokino Integration of hepatitis-B virus-DNA and its implications for hepatocarcinogenesis Mol Biol Med 7 3 1990 243-260
61. Y. Wang S.H. Lau J.S.T. Sham et al. Characterization of HBV integrants in 14 hepatocellular carcinomas: Association of truncated X gene and hepatocellular carcinogenesis Oncogene 23 1 2004 142-148
62. K. Okuda T. Nakashima K. Sakamoto et al. Hepatocellular-carcinoma arising in non-cirrhotic and highly cirrhotic livers-a comparative-study of histopathology and frequency of hepatitis-B markers Cancer 49 3 1982 450-455
63. T. Pollicino G. Squadrito G. Cerenzia et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 1 2004 102-110
64. M. Hohne S. Schaefer M. Seifer et al. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis-B virus-DNA Eur Mol Biol Org J 9 4 1990 1137-1145
65. G. Fourel C. Trepo L. Bougueleret et al. Frequent activation of N-Myc genes by hepadnavirus insertion in woodchuck liver-tumors Nature 347 6290 1990 294-298
66. T.Y. Hsu T. Moroy J. Etiemble et al. Activation of C-myc by woodchuck hepatitis-virus insertion in hepatocellular-carcinoma Cell 55 4 1988 627-635
67. W.S. Robinson Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular-carcinoma Ann Rev Med 45 1994 297-323
68. C. Transy G. Fourel W.S. Robinson et al. Frequent amplification of C-myc in ground-squirrel liver-tumors associated with past or ongoing infection with a hepadnavirus Proc Natl Acad Sci USA 89 9 1992 3874-3878
69. G. Natoli M.L. Avantaggiati P. Chirillo et al. Induction of the DNA-binding activity of C-Jun C-Fos heterodimers by the hepatitis-B virus transactivator Px Mol Cellular Biol 14 2 1994 989-998
70. X.W. Wang K. Forrester H. Yeh et al. Hepatitis-B-virus-x protein inhibits p53 sequence-specific DNA-binding. Transcriptional Activity, and Association With Transcription Factor Ercc3 Proc Natl Acad Sci USA 91 6 1994 2230-2234
71. X.W. Wang M.K. Gibson W. Vermeulen et al. Abrogation of P53-induced apoptosis by the hepatitis-B virus-X gene Cancer Res 55 24 1995 6012-6016
72. C.C. Hsia C.A. Axiotis A.M. Dibisceglie E. Tabor Transforming growth factor-alpha in human hepatocellular-carcinoma and coexpression with hepatitis-B surface-antigen in adjacent liver Cancer 70 5 1992 1049-1056
73. S. Menzo M. Clementi E. Alfani et al. Transactivation of epidermal growth-factor receptor gene by the hepatitis-B virus X-gene product Virology 196 2 1993 878-882
74. D.K. Lee S.H. Park Y. Yi et al. The hepatitis B virus encoded oncoprotein px amplifies tgf-beta family signaling through direct interaction with smad4: Potential mechanism of hepatitis B virus-induced liver fibrosis Genes Dev 15 4 2001 455-466
75. Y.D. Yoo H. Ueda K. Park et al. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator J Clin Investig 97 2 1996 388-395
76. C.M. Kim K. Koike I. Saito et al. Hbx gene of hepatitis-B virus induces liver-cancer in transgenic mice Nature 351 6324 1991 317-320
77. K. Koike K. Moriya S. Iino et al. High-level expression of hepatitis-B virus Hbx gene and hepatocarcinogenesis in transgenic mice Hepatology 19 4 1994 810-819
78. K. Moriya K. Nakagawa T. Santa et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis Cancer Res 61 11 2001 4365-4370
79. F.V. Chisari K. Klopchin T. Moriyama et al. Molecular pathogenesis of hepatocellular-carcinoma in hepatitis-B virus transgenic mice Cell 59 6 1989 1145-1156
80. G.M. Lauer B.D. Walker Medical progress: Hepatitis C virus infection New Engl J Med 345 1 2001 41-52
81. K. Ikeda S. Saitoh I. Koida et al. A multivariate-analysis of risk-factors for hepatocellular carcinogenesis-a prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 1 1993 47-53
82. M.S. de Mitri K. Poussin P. Baccarini et al. Hcv-associated liver-cancer without cirrhosis Lancet 345 8947 1995 413-415
83. L. Benvegnu G. Fattovich F. Noventa et al. Concurrent hepatitis-B and hepatitis-C virus-infection and risk of hepatocellular-carcinoma in cirrhosis-a prospective-study Cancer 74 9 1994 2442-2448
84. G. Ballardini P. Groff F. Giostra et al. Hepatocellular codistribution of C100, C33, C22, and Ns5 hepatitis-C virus-antigens detected by using immunopurified polyclonal spontaneous human-antibodies Hepatology 21 3 1995 730-734
85. G.K.K. Lau G.L. Davis S.P.C. Wu et al. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: A study by in situ reverse-transcription polymerase chain reaction Hepatology 23 6 1996 1318-1323
86. S. Kobayashi H. Hayashi Y. Itoh et al. Detection of minus-strand hepatitis-C virus-RNA in tumor-tissues of hepatocellular-carcinoma Cancer 73 1 1994 48-52
87. R.B. Ray L.M. Lagging K. Meyer et al. Transcriptional regulation of cellular and viral promoters by the hepatitis-C virus core protein Virus Res 37 3 1995 209-220
88. C.M. Shih S.C.J. Lo T. et al. Miyamura Suppression of hepatitis-B virus expression and replication by hepatitis-C virus core protein in Huh-7 cells J Virol 67 10 1993 5823-5832
89. R.B. Ray L.M. Lagging K. Meyer R. Ray Hepatitis C virus core protein cooperates with Ras and transforms primary Rat embryo fibroblasts to tumorigenic phenotype J Virol 70 7 1996 4438-4443
90. R.B. Ray R. Steele K. Meyer R. Ray Transcriptional repression of p53 promoter by hepatitis C virus core protein J Biol Chem 272 17 1997 10983-10986
91. K. Moriya H. Fujie Y. Shintani et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 9 1998 1065-1067
92. M. Gale C.M. Blakely B. Kwieciszewski et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5a protein: Molecular mechanisms of kinase regulation Mol Cell Biol 18 9 1998 5208-5218
93. T. Yamashita S. Kaneko Y. Shirota et al. Polymerase activity of the soluble recombinant hepatitis C virus ns5b protein truncated at the c-terminal region J Biol Chem 273 25 1998 15479-15486
94. C. Niederau R. Fischer A. Sonnenberg et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis New Engl J Med 313 20 1985 1256-1262
95. S. Eriksson J. Carlson R. Velez Risk of cirrhosis and primary liver-cancer in alpha-1-antitrypsin deficiency New Engl J Med 314 12 1986 736-739
96. M.H. Chang D.S. Chen H.C. Hsu et al. Maternal transmission of hepatitis-B virus in childhood hepatocellular-carcinoma Cancer 64 11 1989 2377-2380
97. F.M. Shen M.K. Lee H.M. Gong et al. Complex segregation analysis of primary hepatocellular-carcinoma in chinese families-interaction of inherited susceptibility and hepatitis-B viral-infection Am J Hum Genet 49 1 1991 88-93
98. S.R. Alberts A.P. Lanier B.J. Mcmahon et al. Clustering of hepatocellular-carcinoma in alaska native families Genet Epidemiol 8 2 1991 127-139
99. K. Kawaguchi M. Honda T. Yamashita et al. Detection of DNA copy number alteration in hepatoma cell lines using CDNA microarrays: The direct role of DNA copy number in the transcriptional program of hepatocellular carcinoma (HCC) Hepatology 38 4 2003 403A
100. X. Chen S.T. Cheung S. So et al. Gene expression patterns in human liver cancers Mol Biol Cell 13 6 2002 1929-1939
101. X.R. Xu J. Huang Z.G. Xu et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver Proc Natl Acad Sci USA 98 26 2001 15089-15094
102. Y. Shirota S. Kaneko M. Honda et al. Identification of differentially expressed genes in hepatocellular carcinoma with CDNA microarrays Hepatology 33 4 2001 832-840
103. H. Okabe S. Satoh T. Kato et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using CDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression Cancer Res 61 5 2001 2129-2137
104. A. la Coste B. Romagnolo P. Billuart et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas Proc Natl Acad Sci USA 95 15 1998 8847-8851
105. B. Terris P. Pineau L. Bregeaud et al. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas Oncogene 18 47 1999 6583-6588
106. D.F. Calvisi V.M. Factor R. Loi S.S. Thorgeirsson Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade Cancer Res 61 5 2001 2085-2091
107. O.N. el Assal A. Yamanoi Y. Soda et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver Hepatology 27 6 1998 1554-1562
108. M.A. Kang K.Y. Kim J.Y. Seol et al. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor J Gene Med 2 4 2000 289-296
109. X.M. Li Z.Y. Tang L.X. Qin et al. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma J Exp Clin Cancer Res 18 4 1999 511-517
110. J. Zhou Z.Y. Tang J. Fan et al. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus J Cancer Res Clin Oncol 126 1 2000 57-61
111. R.T.P. Poon I.O.L. Ng C. Lau et al. Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma Am J Surg 182 3 2001 298-304
112. P.I. Hsu N.H. Chow K.H. Lai et al. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma Anticancer Res 17 4A 1997 2803-2809